Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Blood Advances|October 22, 2024
Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysisAmneet Bajwa, Qiuhong Zhao, Marcus Geer, et al.Journal of Clinical Immunology|August 17, 2022
SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK InhibitionThomas F Michniacki, Kelly Walkovich, Lauren DeMeyer, et al.Chest|April 12, 2022
Defibrotide Therapy for SARS-CoV-2 ARDSDavid Frame, Gianni B Scappaticci, Thomas M Braun, et al.Annals of Hematology|March 19, 2015
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remissionJohn M Magenau, Thomas Braun, Pavan Reddy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast CancerCynthia X Ma, Ron Bose, Feng Gao, et al.Blood|August 16, 2011
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesJohn Magenau, Hiromi Tobai, Attaphol Pawarode, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2020
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, et al.Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
Tocilizumab for treatment of mechanically ventilated patients with COVID-19Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, et al.Pageof 5